Sermorelin is a synthetic GHRH analogue that is also unlicensed in the UK and not listed in the BNF for any adult indication
A short reset week (fluids + protein anchor + small regular meals) improves energy for many people
GLP-1 has one of the most extensive published research bases of any peptide hormone in modern biomedical science, with thousands of peer-reviewed studies spanning its discovery, physiology, receptor pharmacology, and the entire GLP-1RA drug class built upon it
For broader peptide therapy Dedicated peptide therapy clinics, both local and telehealth-based, offer access to a much wider range of peptides than Eden
1 In the REIMAGINE 2 trial, the most commonly reported AEs were GI-related, occurring in 405/603 (67.2%) participants in the CagriSema 2.4 mg/2.4 mg group, 326/605 (53.9%) participants in the semaglutide 2.4 mg group, 60/152 (39.5%) participants in the cagrilintide 2.4 mg group, 329/594 (55.4%) participants in the CagriSema 1 mg/1 mg group, 288/608 (47.4%) participants in the semaglutide 1 mg group, and 42/149 (28.2%) participants in the placebo group